Cargando…
How and why do we screen for colorectal cancer?
After almost 50 years of data analysis, screening for colorectal cancer has proven to be an effective tool in reducing colorectal cancer mortality. However, implementing the optimal strategy represents a challenge for many healthcare facilities around the world. There is much discussion regarding ho...
Autores principales: | Chetroiu, Diana, Pop, Corina-Silvia, Filip, Petruta Violeta, Beuran, Mircea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485384/ https://www.ncbi.nlm.nih.gov/pubmed/34621368 http://dx.doi.org/10.25122/jml-2021-0192 |
Ejemplares similares
-
MALT lymphoma: epidemiology, clinical diagnosis and treatment
por: Violeta Filip, Petruta, et al.
Publicado: (2018) -
Myelography in the Age of MRI: Why We Do It, and How We Do It
por: Ozdoba, Christoph, et al.
Publicado: (2011) -
Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020) -
The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023) -
Glycemic Variability: How Do We Measure It and Why Is It Important?
por: Suh, Sunghwan, et al.
Publicado: (2015)